These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 19770064

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene.
    Nett JE, Crawford K, Marchillo K, Andes DR.
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3505-8. PubMed ID: 20516280
    [Abstract] [Full Text] [Related]

  • 24. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ, Bernardo SM, Wiederhold NP, Lee SA.
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [Abstract] [Full Text] [Related]

  • 25. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA, Carvalhaes C, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015043
    [Abstract] [Full Text] [Related]

  • 26. Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.
    Ben-Ami R, Kontoyiannis DP.
    Virulence; 2012 Mar 24; 3(1):95-7. PubMed ID: 22286697
    [Abstract] [Full Text] [Related]

  • 27. Signalling mechanisms involved in stress response to antifungal drugs.
    Víglaš J, Olejníková P.
    Res Microbiol; 2021 Mar 24; 172(1):103786. PubMed ID: 33038529
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of echinocandin antifungal drug resistance.
    Perlin DS.
    Ann N Y Acad Sci; 2015 Sep 24; 1354(1):1-11. PubMed ID: 26190298
    [Abstract] [Full Text] [Related]

  • 29. Current perspectives on echinocandin class drugs.
    Perlin DS.
    Future Microbiol; 2011 Apr 24; 6(4):441-57. PubMed ID: 21526945
    [Abstract] [Full Text] [Related]

  • 30. Echinocandins: the newest class of antifungals.
    Sucher AJ, Chahine EB, Balcer HE.
    Ann Pharmacother; 2009 Oct 24; 43(10):1647-57. PubMed ID: 19724014
    [Abstract] [Full Text] [Related]

  • 31. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS.
    Antimicrob Agents Chemother; 2009 Sep 24; 53(9):3690-9. PubMed ID: 19546367
    [Abstract] [Full Text] [Related]

  • 32. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
    Toutounji M, Tokajian S, Khalaf RA.
    Fungal Genet Biol; 2019 Jun 24; 127():12-22. PubMed ID: 30794951
    [Abstract] [Full Text] [Related]

  • 33. Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans.
    Chavan NL, Young JK, Drezek RA, Lewis R, Bikram M.
    Mol Pharm; 2012 Sep 04; 9(9):2489-96. PubMed ID: 22770505
    [Abstract] [Full Text] [Related]

  • 34. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
    Arendrup MC, Garcia-Effron G, Buzina W, Mortensen KL, Reiter N, Lundin C, Jensen HE, Lass-Flörl C, Perlin DS, Bruun B.
    Antimicrob Agents Chemother; 2009 Mar 04; 53(3):1185-93. PubMed ID: 19104024
    [Abstract] [Full Text] [Related]

  • 35. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
    Katiyar SK, Alastruey-Izquierdo A, Healey KR, Johnson ME, Perlin DS, Edlind TD.
    Antimicrob Agents Chemother; 2012 Dec 04; 56(12):6304-9. PubMed ID: 23027185
    [Abstract] [Full Text] [Related]

  • 36. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
    Niimi K, Monk BC, Hirai A, Hatakenaka K, Umeyama T, Lamping E, Maki K, Tanabe K, Kamimura T, Ikeda F, Uehara Y, Kano R, Hasegawa A, Cannon RD, Niimi M.
    J Antimicrob Chemother; 2010 May 04; 65(5):842-52. PubMed ID: 20233776
    [Abstract] [Full Text] [Related]

  • 37. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2017 Mar 04; 61(3):. PubMed ID: 28052853
    [Abstract] [Full Text] [Related]

  • 38. The role of aneuploidy in the emergence of echinocandin resistance in human fungal pathogen Candida albicans.
    Sah SK, Hayes JJ, Rustchenko E.
    PLoS Pathog; 2021 May 04; 17(5):e1009564. PubMed ID: 34043737
    [No Abstract] [Full Text] [Related]

  • 39. Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs.
    Juvvadi PR, Moseley MA, Hughes CJ, Soderblom EJ, Lennon S, Perkins SR, Thompson JW, Geromanos SJ, Wildgoose J, Richardson K, Langridge JI, Vissers JPC, Steinbach WJ.
    J Proteome Res; 2018 Feb 02; 17(2):780-793. PubMed ID: 29251506
    [Abstract] [Full Text] [Related]

  • 40. Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
    Gregori C, Glaser W, Frohner IE, Reinoso-Martín C, Rupp S, Schüller C, Kuchler K.
    Eukaryot Cell; 2011 Dec 02; 10(12):1694-704. PubMed ID: 22037180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.